TDOC logo

TDOC
Teladoc Health Inc

40,587
Loading...
Loading...
News
all
press releases
3 Medical Service Industry Stocks Poised to Counter Workforce Issues
Here are three resilient medical services stocks, Labcorp, Charles River Laboratories and Teladoc, that are poised to outperform amid staffing shortages and digital healthcare growth.
Zacks·4h ago
News Placeholder
More News
News Placeholder
Is Progyny (PGNY) Stock Undervalued Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·3d ago
News Placeholder
Teladoc (TDOC) Stock Drops Despite Market Gains: Important Facts to Note
Teladoc (TDOC) concluded the recent trading session at $8.57, signifying a -4.88% move from its prior day's close.
Zacks·4d ago
News Placeholder
All You Need to Know About Teladoc (TDOC) Rating Upgrade to Buy
Teladoc (TDOC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·4d ago
News Placeholder
Strength Seen in Teladoc (TDOC): Can Its 6.3% Jump Turn into More Strength?
Teladoc (TDOC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·4d ago
News Placeholder
OptimizeRx Bets on AI and Workflow Integration - Will This Pay Off?
OPRX posts 55% revenue growth and raises outlook as AI-driven workflow integration fuels leverage and pharma adoption.
Zacks·10d ago
News Placeholder
Teladoc (TDOC) Rises As Market Takes a Dip: Key Facts
In the latest trading session, Teladoc (TDOC) closed at $8.37, marking a +2.2% move from the previous day.
Zacks·17d ago
News Placeholder
Teladoc (TDOC) Increases Despite Market Slip: Here's What You Need to Know
In the latest trading session, Teladoc (TDOC) closed at $7.87, marking a +2.61% move from the previous day.
Zacks·24d ago
News Placeholder
Hims & Hers Expands AI and Technology Focus to Advance Digital Care
HIMS boosts AI investment and appoints a new CTO as it advances personalized, technology-driven digital healthcare at scale.
Zacks·24d ago
News Placeholder
Hims & Hers Surges 64.1% in 6 Months: How to Play the Stock?
HIMS accelerates with new men's health launches, global expansion plans and strong subscriber-driven growth, but rising costs strain gross margins.
Zacks·28d ago

Latest TDOC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.